FSDDF News and Press, FSD Pharma Inc - Class B From 12/13/19

FSD Pharma to Present at Investor Summit on December 17 Canada NewsWire TORONTO, Dec. 13, 2019 TORONTO , Dec. 13, 2019 /CNW/ -  FSD Pharma Inc. (CSE: HUGE) (OTCQB: FSDDF) (FRA: 0K9)  ("FSD Pharma" or the "Company") announces that Raza Bokhari , MD, Executive Co...

FSD Pharma Inc. (CSE: HUGE) (OTCQB: FSDDF) (FRA: 0K9) ("FSD Pharma" or the "Company") announces that Edward Brennan, MD, President, BioSciences Division, will present an overview of the Company at the 12 th Annual LD Micro Main Event Investor conference at 12:20 p.m. PT/3:20 p.m. ET on Wed...

FSD Pharma ( OTCQB:FSDDF ): Q3 GAAP EPS of -C$2.20. More news on: FSD Pharma Inc., Earnings news and commentary, Consumer stocks news, , Read more ...

FSD Pharma Reports Third Quarter 2019 Financial Results Canada NewsWire TORONTO, Nov. 29, 2019 - Announces intent to initiate Phase 1 first-in-human safety and tolerability trials for its lead candidate, PP 101 micro-PEA during 1Q20 – - Raises $4.59 ...

FSD Pharma Second Tranche of Private Placement Closes, Total of $4.59 Million Raised at $20.10 To Date, Extends Offering Canada NewsWire TORONTO, Nov. 4, 2019 /THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED ST...

FSD Pharma Announces the Filing of an Amended Annual MD&A for 2018 FSD Pharma Announces the Filing of an Amended Annual MD&A for 2018 Canada NewsWire TORONTO, Oct. 23, 2019 TORONTO , Oct. 23, 2019 /CNW/ - FSD Pharma Inc. (CSE: HUGE) (OTCQB: FSDDF) (FRA: 0K9...

FSD Pharma Announces Temporary Change in OTCQB Ticker Symbol to FSDDD Canada NewsWire TORONTO, Oct. 17, 2019 TORONTO , Oct. 17, 2019 /CNW/ - FSD Pharma Inc. (CSE: HUGE) (OTCQB: FSDDD) (FRA: 0K9) ("FSD" or the "Company") today announced that the Company's Class B Shares ar...

FSD Pharma Closes First Tranche of Private Placement at $4.58 Million, Extends Offering Canada NewsWire TORONTO, Oct. 1, 2019 TORONTO , Oct. 1, 2019 /CNW/ - FSD Pharma Inc. (CSE: HUGE) (OTCQB: FSDDF) (FRA: 0K9) (" FSD " or the " Company ") is pleased to provide an up...

Vancouver, British Columbia--(Newsfile Corp. - September 26, 2019) - FSD Pharma Inc. (CSE: HUGE) (FSE: 0K9) (OTCQB: FSDDF), through its wholly-owned subsidiary FV Pharma, has signed a letter of intent with World Class Extractions (CSE: PUMP) (FSE: WCF) to create a joint venture to develop, man...

- Joint Venture to develop, manage and operate cannabis extraction and processing center at FSD Pharma Facility in Cobourg, Ontario - FSD Pharma Inc. (CSE: HUGE) (OTC: FSDDF) (FRA: 0K9) (“FSD Pharma”, “FSD” or “the Company”) today announced t...